---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041716"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-09-08T13:00:42+00:00"
generated_at: "2026-09-08T13:02:08.099903+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics signs exclusive distribution deal with Akron Biotech for HCW11-006 reagent

## Summary
- Exclusive worldwide distribution (ex-China) of HCW11-006 as CAR-T manufacturing reagent; 5-year term.
- Advance payments: $200k at closing, $100k within 30 days of Supply Agreement, $100k on each of 1st and 2nd anniversaries.
- Closing by Nov 30, 2026, subject to due diligence and product testing; Supply Agreement to be negotiated within 60 days of closing.
- HCW11-006 is a multi-cytokine fusion molecule; preclinical data show CAR-Ts made with it have enhanced anti-tumor and antiviral activity.
- Akron is a leading supplier of ancillary materials for cell/gene therapy; deal marks first commercialization of HCW's TRBC platform product.

## SEC filing metadata
- accession: 0001493152-26-041716
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-09-08T13:00:42+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226041716/0001493152-26-041716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226041716/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041716
- JSON: https://secwatch.observer/filing/0001493152-26-041716.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.